Click here for more information about Algenuity
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Evodos Separation Technology Check out more of The Buzz spacer

Algae.Tec to license pharmaceutical delivery platform using algal oils

February 12, 2018
AlgaeIndustryMagazine.com

Plant-based health and wellbeing company Algae.Tec Limited (AEB) has announced that it has entered into a binding Heads of Agreement (HOA) to acquire a significant interest in private Australian-based pharmaceutical delivery company, NS Technologies Pty Ltd (NST).

NS Technologies Pty Ltd is a Western Australian business founded in 2007 which has developed and patented a unique and effective pharmaceutical delivery system for topical (spray and patch), nasal and sub-lingual applications, which enables pharmaceuticals to be delivered without the use of a syringe, or ingesting a pill or potion, or through any direct inhalation procedure.

The mini-emulsion delivery system comprises emulsion “droplets” within which the bioactive compound is captured. This provides a controlled presentation of the substance to the body. The mini emulsion droplets filter through the epidermal layer, in an effective, “slow release” manner, allowing lower dosages, with an effective outcome. This mini emulsion base component requires a selected vegetable oil, which is ideally suited to specific algal oils.

The NST delivery platform was patented after successful clinical trials, supervised by Professor Fiona Woods, Australia’s leading burn victim specialist, at Royal Perth Hospital in 2011 and 2012. The technology is one where a “mini-emulsion” was developed to allow complex molecules, up to 1000 in molecular weight, to penetrate the epidermis skin layer, and enter the subdermal layer of the human body.

Under the agreement, AEB will acquire 19.9% of NST and exclusively license a patented delivery platform technology developed by NST for use across any medical application developed by AEB. NST has also agreed to use AEB’s algae oil as the base component of its emulsion delivery platform.

AEB will collaborate with NST’s in-house team to develop a range of mini-emulsion pharmaceutical products to be used across a range of medicinal applications for both human and veterinary purposes using selected algal oils.

“This partnership delivers AEB the exclusive global use of a truly unique and proven delivery system, providing the Company with operations across all phases of the pharma value chain, from algal oil production through to pharmaceutical delivery,” said Algae.Tec’s Executive Chairman and Managing Director, Malcolm James.

“This agreement is highly complementary to AEB’s existing algae and medicinal cannabis operations,” he said, “and will provide significant optionality to both of these respective divisions as the partnership with NST evolves. Looking ahead, AEB has a number of other high-growth and also complementary initiatives in the pipeline and we look forward to sharing these with shareholders very soon.”

NST Founding Director, Alan Leeming, added, “We are very pleased to be partnering with AEB and believe their expertise in the plant-based health and wellness sector will be a significant benefit to our business moving forward. Like so many patented inventions, this pharmaceutical delivery technology has been nearly two decades in the making and we are now entering a very exciting period in the development of this delivery platform. We look forward to building this relationship with AEB in the near-term as we capitalize on a number of commercial opportunities in the global pharmaceutical delivery space.”

More Buzz…

Copyright ©2010-2018 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
“The Israeli food-tech industry has been growing in leaps and bounds in recent years and is taking a leading role worldwide with a broad range of innovative companies and...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...
French researchers have been exploring the potential of algae for boosting the immune systems of animals and reducing the use of antibiotics in livestock farming. Past st...
JapanNews.com reports that Euglena Co., a Tokyo-based maker of nutritional supplements, is spending ¥5.8 billion ($5.3 million USD) on building a test refinery that conve...
At the Technical University of Denmark (DTU), Science Nordic.com reports, researchers are investigating bioluminescent algae, to determine whether bioluminescent organism...
Hayley Dunning writes from the Imperial College of London that a new discovery has changed our understanding of the basic mechanism of photosynthesis and should rewrite t...
Sophie Kevany writes in Decanter.com that a group of vineyards in France’s Bordeaux and Cognac regions are exploring whether algae can be used to prevent the fungal infec...
The Swiss Algae Consortium Association (SWALG) was founded in May 2018 as a non-profit organization that serves as a platform for algae-related activities in Switzerland ...
Alexander Richter reports for Geothermal Energy News that, among the many examples offered during a recent conference in Pisa, Italy, on Perspectives and Impact of the Gr...
Nature.com reports that swimming algae have been enlisted to carry drugs to individual cells, raising the prospect that such “microswimmers” could deliver targeted therap...
Julianna Photopoulos writes in Horizon EU Research and Innovation magazine that UK start-up Skipping Rocks Lab aims to use natural materials extracted from plants and sea...
Mazda U.K. has announced that they are currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promo...